Adial Pharmaceuticals announced the appointment of Tony Goodman as Chief Operating Officer. A highly accomplished pharmaceutical industry executive and member of Adial’s Board of Directors since 2017, Goodman will oversee the Company’s strategic growth initiatives, including clinical development and commercial planning for AD04, as well as business development initiatives focused on partnership opportunities in the area of addiction treatment. He will continue to serve on Adial’s Board.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on ADIL:
- Adial Announces Appointment of Tony Goodman as Chief Operating Officer
- Adial Pharmaceuticals files $100M mixed securities shelf
- Adial Pharmaceuticals receives final reimbursement payment from Adovate
- Adial Pharmaceuticals Receives Final Reimbursement Payment from Adovate
- Adial Pharmaceuticals receives noncompliance notification from Nasdaq
